Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)Eiji Oki, Yoshihiko Maehara, Takeharu Yamanaka et al.|British Journal of Cancer|2019Cited by 61